In accordance with studies suggesting that TGF-β1 can act as a tumor suppressor [41], BCSCs formed fewer spheres in 3D sphere formation assays using 50% Matrigel upon TGF-β1 treatment (Figure 4E). Here, TGFB1 is linked to neoplasm.